MedPath

Gut Inflammation Markers as Determinants of Response to Recovery in Uncomplicated Severely Malnourished Childre

Not Applicable
Completed
Conditions
Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseasesHealth Condition 2: null- Uncomplicated severe acute malnutrition
Registration Number
CTRI/2016/02/006656
Lead Sponsor
Society for Applied Studies
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

Age 6 to 59 months

- SAM, defined as Weight for height less than -3 SD of WHO standard or oedema of both feet, or both.

Exclusion Criteria

- Complicated SAM defined as child with SAM having signs of severe illness requiring hospitalization

- Known allergy to animal milk or peanuts

- Likely to leave the study area permanently in the next 16 weeks

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gut inflammation at enrolment by presence of elevated specified biomarkers and gut microbiota. <br/ ><br> <br/ ><br>Persistence of gut inflammation during early treatment phase (at recovery or 8 weeks post enrolment, whichever is earlier). <br/ ><br> <br/ ><br>Association between gut inflammation biomarkers, gut microbiota at enrolment and recovery and gain in weight and length/ height. <br/ ><br> <br/ ><br>Association between anorexia during the treatment phase and recovery and gain in weight and length/ height. <br/ ><br>Timepoint: Enrollment <br/ ><br> <br/ ><br> <br/ ><br>Recovery or 8 Weeks <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Enrolment to 16 Weeks <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Enrolment to 16 Weeks <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Examine microbioata of infants who recover and those that do not recover at recovery or 8 weeks. <br/ ><br> <br/ ><br>Assess association between inflammation and microbiota.Timepoint: recovery or 8 weeks
© Copyright 2025. All Rights Reserved by MedPath